In:
PLOS ONE, Public Library of Science (PLoS), Vol. 17, No. 2 ( 2022-2-25), p. e0264503-
Abstract:
UNAIDS’ HIV treatment targets require that 90% of people living with HIV/AIDS (PLWHA) receiving antiretroviral treatment (ART) achieve viral suppression and 90% of people with viral suppression have good health-related quality of life (HRQOL). This study aimed to examine the association of depression and antidepressant therapy with ART adherence and HRQOL in HIV-infected men who have sex with men (MSM). From 2018 through 2020, HIV-infected MSMs were consecutively recruited ( N = 565) for the evaluation of ART adherence and HRQOL at Taipei City Hospital HIV clinics. Non-adherence to ART was defined as a Medication Adherence Report Scale score of 〈 23. HRQOL in PLWHHA was evaluated using WHOQOL-BREF, Taiwan version. Overall, 14.0% had depression and 12.4% exhibited non-adherence to ART. The nonadherence proportion was 21.8% and 10.5% in depressed and nondepressed HIV-infected MSM, respectively. After adjusting for other covariates, depression was associated with a higher risk of nonadherence to ART (adjusted odds ratio = 2.02; 95% confidence interval: 1.02–4.00). Physical, psychological, social, and environmental HRQOL were significantly negatively associated with depression. Considering antidepressant therapy, ART nonadherence was significantly associated with depression without antidepressant therapy but not with antidepressant therapy. The depressed HIV-infected MSM without antidepressant therapy had worse psychological, social, and environmental HRQOL than those with antidepressant therapy. Our study suggests that depression is associated with poor ART adherence and HRQOL, particularly in those without antidepressant therapy. Adequate diagnosis and treatment of depression should be provided for PLWHA to improve their ART adherence and HRQOL.
Type of Medium:
Online Resource
ISSN:
1932-6203
DOI:
10.1371/journal.pone.0264503
DOI:
10.1371/journal.pone.0264503.t001
DOI:
10.1371/journal.pone.0264503.t002
DOI:
10.1371/journal.pone.0264503.t003
DOI:
10.1371/journal.pone.0264503.t004
DOI:
10.1371/journal.pone.0264503.t005
DOI:
10.1371/journal.pone.0264503.s001
DOI:
10.1371/journal.pone.0264503.s002
DOI:
10.1371/journal.pone.0264503.s003
DOI:
10.1371/journal.pone.0264503.s004
DOI:
10.1371/journal.pone.0264503.s005
DOI:
10.1371/journal.pone.0264503.r001
DOI:
10.1371/journal.pone.0264503.r002
DOI:
10.1371/journal.pone.0264503.r003
DOI:
10.1371/journal.pone.0264503.r004
Language:
English
Publisher:
Public Library of Science (PLoS)
Publication Date:
2022
detail.hit.zdb_id:
2267670-3
